-
1 Comment
PharmaCielo Ltd is currently in a long term downtrend where the price is trading 13.2% below its 200 day moving average.
From a valuation standpoint, the stock is 91.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 84.7.
PharmaCielo Ltd's total revenue sank by 80.1% to $26K since the same quarter in the previous year.
Its net income has dropped by 60.0% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 40.7% to $-7M since the same quarter in the previous year.
Based on the above factors, PharmaCielo Ltd gets an overall score of 2/5.
ISIN | CA71716K1012 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Exchange | V |
CurrencyCode | CAD |
PE Ratio | None |
---|---|
Target Price | 2.5 |
Beta | 1.96 |
Market Cap | 11M |
Dividend Yield | None |
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with Benuvia Operations, LLC to produce cGMP pharmaceutical-grade CBD active pharmaceutical ingredients. PharmaCielo Ltd. is headquartered in Toronto, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PCLO.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025